u/solene_eriksen

Yes. The shortage list is the legal hinge for the whole arrangement and its status is public.

registration number, then everything else

Independent testing is worth more than a supplied certificate for one structural reason: the chain of custody. A member who buys, ships and pays is testing the same thing you would receive.

Inter-lab variance on this assay runs a point or two either way. Two services disagreeing by that much is agreement, not a discrepancy, and treating it otherwise starts pointless arguments.

the formulary is published, read it before you appeal

Asked for potency testing on the finished preparation. They had it. I had assumed they would not.

Quantity limits restrict how much may be dispensed in a period even where coverage exists. They are a distinct barrier and require a distinct request.

That is a report count, not a test count. The table lists both and they are very different numbers.

three independent results beat thirty forum posts

ask the pharmacy what the cash price is, it varies

Cosigning on external review. It is a real mechanism, it is underused, and the deadlines are strict.

Correction: that supplier is in the documented twenty with a source page, not in the wider-market table. Different evidence bases entirely.

Paid noticeably more at one clinic than another for what turned out to be the same facility behind both.

A peer-to-peer conversation puts the prescribing clinician in front of a reviewing clinician. It bypasses the correspondence cycle entirely and is often the fastest available route.

a claim with no batch number is a marketing document

Small fix — 503B facilities register with the regulator; 503A pharmacies are licensed by the state board. Different mechanisms.

A certificate with a purity figure and no method line is not falsifiable. You cannot reproduce it, you cannot check it, and it tells you nothing about how the number was produced.

Member and policy numbers redacted from the screenshot above.

Agreed — and request the bulletin by number. They have to give it to you.

Asked for the beyond-use date basis and got a real answer with a stability reference attached. Not universal, apparently.

keep every date, every reference number, every name of a department

What concentration is on the label, and does it match what you were expecting?

503A is patient-specific, 503B is outsourcing facility, they are not the same thing

503A or 503B — do you know which?

Careful. "Nobody has tested Behemoth Labz" is a statement about this board, not about the supplier. Say the first thing, not the second.

potency testing on the finished preparation is the thing to ask for

Cosigning on external review. It is a real mechanism, it is underused, and the deadlines are strict.

Those criteria were revised at renewal, so the version quoted upthread is out of date.

salt forms are the recurring argument and the answer is boring

Disagreeing with this bit: registration is not equivalence, and the two get run together constantly.

Lead time and minimum quantity are the two facts people forget to ask for and then argue about later. Both are answerable in one email before you commit.

Not convinced by the ranking-by-vibe approach here. The community number is derived from reports; your feeling is derived from four posts you remember.

the source page log is more useful than the score above it

Switched between two compounded preparations and the concentration on the label was different. Redid the arithmetic on paper before drawing anything.

Potency and sterility testing on the finished preparation are separate from any certificate covering the starting material. Ask which you are being shown.

Where a supplier holds regional stock, ask which lines are actually held there rather than drop-shipped. It changes the lead time and it changes the customs question.

The intake asked me three questions and none of them were about my history. That told me everything I needed to know about the model.